| Literature DB >> 32489352 |
Anna Chmielowiec-Korzeniowska1, Leszek Tymczyna1, Łukasz Wlazło1, Bożena Nowakowicz-Dębek1, Beata Trawińska1.
Abstract
INTRODUCTION: At present, infections induced by staphylococci, especially methicillin-resistant Staphylococcus aureus (MRSA) are one of key therapeutic and epidemiological problems. AIM: The assessment of Staphylococcus aureus carrier state occurrence among a healthy adult population as well as determination of phenotypic and genotypic properties of the isolated strains.Entities:
Keywords: Staphylococcus aureus; carriage; polymerase chain reaction
Year: 2020 PMID: 32489352 PMCID: PMC7262795 DOI: 10.5114/ada.2020.94837
Source DB: PubMed Journal: Postepy Dermatol Alergol ISSN: 1642-395X Impact factor: 1.837
Number and percentage of identified Staphylococcus aureus as regards isolation site
| Sampling site | Number of samples | Number of | Number of |
|---|---|---|---|
| Pharynx | 100 | 60 (100%) | 24 (40%) |
| Nasal vestibule | 100 | 64 (100%) | 18 (28%) |
| Nares | 100 | 80 (100%) | 2 (2.5%) |
| Total | 300 | 204 (100%) | 44 (22%) |
Figure 1Number of adults with Staphylococcus aureus positive colonization
Questionnaire results with respondents’ health proneness factor
| Characteristics | Total | ||||
|---|---|---|---|---|---|
| Negative | Positive | ||||
| Number of subjects | 100 (100%) | 68 (100%) | 32 (100%) | – | – |
| Age, mean ± SD | 32.8 ±10.4 | 33.9 ±10.9 | 30.7 ±9.2 | 0.142 | 0.158 |
| Gender (female) | 55 (55%) | 37 (54%) | 18 (56%) | 0.017 | 0.865 |
| Nicotine addiction | 28 (28%) | 20 (29%) | 8 (25%) | –0.046 | 0.651 |
| Dietary supplementation | 28 (28%) | 19 (28%) | 9 (28%) | 0.002 | 0.985 |
| Frequent incidence of upper respiratory tract diseases | 52 (52%) | 36 (53%) | 16 (50%) | –0.027 | 0.786 |
| Earlier diagnosed pharyngeal | 27 (27%) | 19 (28%) | 8 (25%) | –0.031 | 0.760 |
| Earlier diagnosed nasal | 17 (17%) | 12 (18%) | 5 (16%) | –0.025 | 0.804 |
| Contact with hospital setting | 15 (15%) | 11 (16%) | 4 (13%) | –0.048 | 0.635 |
| Frequent antibiotic agent use | 27 (27%) | 21 (31%) | 6 (19%) | –0.127 | 0.206 |
| Common colds last month | 25 (25%) | 15 (22%) | 10 (31%) | 0.099 | 0.327 |
| Antibiotic agent used last month | 1 (1%) | 1 (1%) | 0 | –0.069 | 0.495 |
| Skin problems (oily/mixed) | 78 (78%) | 51 (75%) | 27 (84%) | 0.106 | 0.296 |
Characteristics of Staphylococcus aureus isolates
| Sampling site | Number of subjects | Phenotypic properties | Genotypic properties | |||||
|---|---|---|---|---|---|---|---|---|
| Lipid degradation | Mannitol degradation | Catalase presence | CF factor | Gene nuc | Gene mecA | Gene coa | ||
| Pharynx | 24 (100%) | 12 (50%) | 24 (100%) | 24 (100%) | 22 (92%) | 24 (100%) | 0 | 22 (92%) |
| Nasal vestibule | 18 (100%) | 8 (44%) | 18 (100%) | 18 (100%) | 18 (100%) | 18 (100%) | 0 | 16 (89%) |
| Nares | 2 (100%) | 0 | 2 (100%) | 2 (100%) | 2 (100%) | 2 (100%) | 0 | 1 (50%) |
| Total | 44 (100%) | 10 (23%) | 44 (100%) | 44 (100%) | 42 (95%) | 44 (100%) | 0 | 39 (89%) |
Assessment of slime-formation ability of Staphylococcus aureus strains
| Sampling site | Number of subjects | Strong production | Moderate production | No production |
|---|---|---|---|---|
| Pharynx | 24 (100%) | 9 (38%) | 5 (21%) | 10 (41%) |
| Nasal vestibule | 18 (100%) | 8 (44%) | 3 (17%) | 7 (39%) |
| Nares | 2 (100%) | 1 (50%) | 1 (50%) | 0 |
| Total | 44 (100%) | 18 (41%) | 9 (20%) | 17 (39%) |